US Bancorp

US Bancorp Portfolio holdings

AUM $79.4B
1-Year Est. Return 14.74%
This Quarter Est. Return
1 Year Est. Return
+14.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$74.8B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,422
New
Increased
Reduced
Closed

Top Buys

1 +$463M
2 +$238M
3 +$93.2M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$78.3M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$78.2M

Top Sells

1 +$545M
2 +$417M
3 +$56.4M
4
MSFT icon
Microsoft
MSFT
+$40.9M
5
AAPL icon
Apple
AAPL
+$34.4M

Sector Composition

1 Technology 12.72%
2 Financials 8.33%
3 Healthcare 6.69%
4 Industrials 4.98%
5 Consumer Staples 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URTH icon
4176
iShares MSCI World ETF
URTH
$5.9B
-290
URTY icon
4177
ProShares UltraPro Russell2000
URTY
$414M
-507
UYLD icon
4178
Angel Oak UltraShort Income ETF
UYLD
$1.12B
-19,500
VALU icon
4179
Value Line
VALU
$360M
-125
VFMO icon
4180
Vanguard US Momentum Factor ETF
VFMO
$1.2B
-10
VTES icon
4181
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$1.33B
-550
WATT icon
4182
Energous
WATT
$20.1M
0
WEST icon
4183
Westrock Coffee
WEST
$457M
-275
XBIT icon
4184
XBiotech
XBIT
$75.6M
-100
XONE icon
4185
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$652M
-275
XPEL icon
4186
XPEL
XPEL
$964M
-270
YMAB
4187
DELISTED
Y-mAbs Therapeutics
YMAB
-23
ZIP icon
4188
ZipRecruiter
ZIP
$372M
-7,696
KYTX icon
4189
Kyverna Therapeutics
KYTX
$305M
-4,600
MSTY icon
4190
YieldMax MSTR Option Income Strategy ETF
MSTY
$3.45B
-1,696
MTUS icon
4191
Metallus
MTUS
$701M
-139
BODI icon
4192
The Beachbody Company
BODI
$39.7M
-6
ENTO
4193
Entero Therapeutics
ENTO
$10.8M
0
INCE
4194
Franklin Income Equity Focus ETF
INCE
$97.8M
-1,381
ONIT
4195
Onity Group
ONIT
$302M
-370
ARDT
4196
Ardent Health
ARDT
$2.09B
-1,834
NESR
4197
National Energy Services Reunited Corp
NESR
$1.04B
-83
FLG.PRU
4198
Flagstar Financial Bifurcated Option Note Unit SecuritiES
FLG.PRU
$115M
-287
PVLA
4199
Palvella Therapeutics
PVLA
$840M
-138
NVRO
4200
DELISTED
NEVRO CORP.
NVRO
-11,348